1. Volume 54, Issue 4, Pages 938-941 (October 2008)
Durable Complete Response to Frontline Docetaxel in an Advanced Prostate Cancer Patient with Favourable CYP1B1 Isoforms: Suggestion for Changing Paradigms? 
Giovanni Brandi, Francesco de Rosa, Romano Danesi, Gian Carlo Montini, Guido Biasco 
European Urology 
Volume 54, Issue 4, Pages (October 2008)
DOI: /j.eururo
Copyright © 2008 European Association of Urology Terms and Conditions

2. Fig. 1
11C-choline positron-emission tomography/computed tomography (PET/CT) performed after surgery showing a high tracer uptake area in the prostatic lodge (yellow in the fusion image on the left), strongly suggestive of residual disease.
European Urology  , DOI: ( /j.eururo )
Copyright © 2008 European Association of Urology Terms and Conditions

3. Fig. 2
11C-choline positron-emission tomography/computed tomography (PET/CT) performed after surgery, sagittal section; a high tracer uptake area is shown (centre of the yellow cross), corresponding to a lumbar aortic lymph node. This finding is strongly suggestive of disease presence in a lymph node not removed during the surgical procedure.
European Urology  , DOI: ( /j.eururo )
Copyright © 2008 European Association of Urology Terms and Conditions

4. Fig. 3
11C-choline positron-emission tomography/computed tomography (PET/CT) performed after docetaxel therapy, same section as Fig. 1. The high tracer uptake area previously identified in the prostatic lodge has disappeared.
European Urology  , DOI: ( /j.eururo )
Copyright © 2008 European Association of Urology Terms and Conditions

5. Fig. 4
11C-choline positron-emission tomography/computed tomography (PET/CT) performed after docetaxel therapy, same section as Fig. 2. The high tracer uptake area previously identified, corresponding to a lumbar aortic lymph node, has disappeared.
European Urology  , DOI: ( /j.eururo )
Copyright © 2008 European Association of Urology Terms and Conditions